3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
5
OTHER_GOV
2
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Lung Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Wilms Tumor
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Sarcoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Adenocarcinoma of Lung
2
Adenocarcinoma Of Esophagus
2
Vaginal Neoplasms
1
Urethral Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Radiation Injuries
1
Radiation Fibrosis Syndrome
1
Prostatic Neoplasms
1
Postoperative Complications
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Interventions
Paclitaxel
15
Carboplatin
15
Taxes
9
Cisplatin
8
Topotecan
4
Docetaxel
4
Filgrastim
3
pegfilgrastim
2
paclitaxel poliglumex
2
liposomal doxorubicin
2
Methods
2
Gemcitabine
2
GEN-1
2
Etoposide
2
Erlotinib Hydrochloride
2
Educational Status
2
Early Intervention, Educational
2
Chemotherapy, Adjuvant
2
vandetanib
1
rilotumumab
1
oregovomab
1
motesanib diphosphate
1
elesclomol
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Watchful Waiting
1
VTX-2337
1
Trabectedin
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Fallopian Tube Neoplasms
×
Surgical Procedures, Operative
×
Clear all
NCT00008138
2016-01-08
S0009
SWOG Cancer Research Network
Phase 2
Completed
62 enrolled
9 charts